Claudia Kesch

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

30h-index3.8kcitations187works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(103), Prostate Cancer Diagnosis and Treatment(102), Urologic and reproductive health conditions(30), Radiomics and Machine Learning in Medical Imaging(21), Bladder and Urothelial Cancer Treatments(17)

Publications185 total

Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology—Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
European Urology Oncology·2025
Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
Prognostische waarde van PSMA PET/CT in het voorspellen van de biochemisch recidiefvrije overleving na radicale prostatectomie in miN0-patiënten
Tijdschrift voor Urologie·2025Open Access
Reply to the Letter to the Editor: Current use of percutaneous ablation in renal tumors—an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy
European Radiology·2025Open Access
PSMA-PET vs. conventional imaging for preoperative staging high-risk PCa patients underwent surgery for cN0M0 disease: an European Association of Urology-Young Academic Urologists Prostate Cancer Working Group multi-institutional study
European Urology Open Science·2025Open Access
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant
JNCI Journal of the National Cancer Institute·2025Open Access
2597MO [68Ga]Ga-DPI-4452 PET/CT for staging of patients with clear cell renal cell carcinoma
Annals of Oncology·2025
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
The Lancet Oncology·2025· 18 citedOpen Access
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy
European Journal of Nuclear Medicine and Molecular Imaging·2025· 2 citedOpen Access
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
European Urology·2025· 21 citedOpen Access
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer
Prostate Cancer and Prostatic Diseases·2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy Procedures
European Urology Open Science·2025· 9 citedOpen Access
PD30-01 THE HIGHEST GRADE GROUP DOES NOT DRIVE THE RISK OF ADVANCED STAGE WHEN SYSTEMATIC AND MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MRI)-TARGETED BIOPSIES ARE DISCORDANT: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES
The Journal of Urology·2025
IP05-27 TRANSCRIPTOMIC PROFILING OF THE TUMOR IMMUNE MICROENVIRONMENT REVEALS PROGNOSTIC MARKERS IN MCRPC PATIENTS TREATED WITH LUPSMA THERAPY
The Journal of Urology·2025
Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group
European Urology Open Science·2025· 3 citedOpen Access
PD30-07 CONVENTIONAL PSMA-PET/CT, MPMRI AND INTRAOPERATIVE EX VIVO SPECIMENPET/CT FOR THE ASSESSMENT OF ACCURACY OF EXTRAPROSTATIC EXTENSION – POTENTIAL OF MOLECULAR-GUIDED NERVE SPARING
The Journal of Urology·2025
PD13-12 EARLY ONCOLOGICAL OUTCOMES OF VERY HIGH-RISK PROSTATE CANCER PATIENTS ACCORDING TO THE STAMPEDE TRIAL DEFINITION IN THE PSMA-PET ERA: IMPLICATION FOR THE SELECTION OF THE OPTIMAL SURGICAL CANDIDATE
The Journal of Urology·2025
MP13-07 CAN A NEGATIVE PSMA PET EXCLUDE THE PRESENCE OF LYMPH NODE METASTASIS IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY? AN INDIVIDUAL PATIENT DATA ANALYSIS FROM A LARGE, MULTI-INSTITUTIONAL COHORT
The Journal of Urology·2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging·2025· 4 citedOpen Access
Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical Cystectomy
Clinical Genitourinary Cancer·2025
page 1 of 10Next →

Frequent Co-authors

Boris Hadaschik(29), Jan Philipp Radtke(21), David Bonekamp(13), Markus Hohenfellner(13), Frederik L. Giesel(10), Giancarlo Marra(10), Christopher Darr(9), Fabio Zattoni(9), Giorgio Gandaglia(9), Uwe Haberkorn(8), Clemens Kratochwil(8), Wolfgang P. Fendler(8), Veeru Kasivisvanathan(8), Felix Preißer(8), Massimo Valério(8), Jens Cardinale(6), Stefan Duensing(6), Klaus Kopka(6), Ulrich Krafft(6), Stephan Tschirdewahn(6)